ExeVir Bio is harnessing a llama-derived antibody technology platform to generate robust antiviral therapies against coronaviruses.
COVID-19
South Korea has attracted entrepreneurs from around the world who are eager to grow their businesses during the pandemic.
In the first half of 2020, investors globally put $16.55 billion to work in biotech and life science sectors.
This latest investment brings the total raised to £65 million, and will be used to consolidate the company’s market share in the U.K. and to fund its...
Venture investment in Latin America is more than doubling every year. The region is turning to startups to help overcome the impact of COVID-19.
In a mid-year check-in on unicorn status, we find that software services and online education have grown as new unicorn candidates while fintech and...
A close look at the data reveals the impact COVID-19 has had on the VC landscape.
A look at shopper engagement from the 2020 Mobile Shopping Apps Report.
Tech news items for this week from our friends at Tech.eu.
CareAcademy provides ongoing online training programs for senior care professionals, in an effort to allow the aged population to stay in their homes...
A survey conducted by NFX in late May found that VCs and founders project the recovery period to extend beyond April 2021.
Featured
23.9K Followers